PNTG

The Pennant Group Inc.

Price

$41.26

return (12m)

74.51%

p/e

45.04

p/bv

3.60

DIVIDEND YIELD

0.00%

PNTG price

Pennant Group

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*The amount considers the reinvestment of dividends.

Return on Investment PNTG

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

5.29%

3 months

1.59%

1 year

74.51%

2 years

18.38%

5 years

75.78%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals PNTG

Valuation

P/E

45.04

Sector 0.84

Industry 8.53

P/BV

3.60

Sector 1.82

Industry 3.48

P/Revenue (PSR)

1.32

Sector 1.48

Industry 3.01

EV/EBITDA

76.69

Sector -43.66

Industry -13.49

EV/EBIT

89.81

Sector -47.57

Industry -80.34

P/EBITDA

19.82

Sector -31.25

Industry 7.08

P/EBIT

23.00

Sector -42.58

Industry -31.12

P/Total Assets

1.40

Sector 0.82

Industry 1.27

P/Net Current Assets

-3.24

Sector -23.77

Industry -3.37

P/Working Capital

46.68

Sector -3.73

Industry 6.96

EPS

0.93

Sector -0.70

Industry -0.23

BVPS

11.61

Sector 4.50

Industry 8.61

Efficiency

Gross Margin

18.51%

Sector 49.32%

Industry 55.16%

EBITDA Margin

7.15%

Sector -305.63%

Industry -13.47%

EBIT Margin

5.65%

Sector -19.73%

Industry -5.67%

Net Profit Margins

2.93%

Sector -23.90%

Industry -7.67%

Asset Turnover

0.29

Sector 0.13

Industry 0.13

Profitability

ROE

7.99%

Sector -24.30%

Industry -24.00%

ROA

3.12%

Sector -24.50%

Industry -5.96%

ROIC

5.70%

Sector -584.46%

Industry -21.90%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

0.00%

Sector -

Industry -

Debt

Current Ratio

1.20

Sector 1.92

Industry 2.56

Net Debt / EBITDA

8.32

Sector -23.10

Industry 9.41

Net Debt / EBIT

9.75

Sector -17.84

Industry -2.82

Net Debt / Equity

0.44

Sector -0.68

Industry -0.19

Gross Debt / Equity

0.48

Sector -0.72

Industry 0.42

Equity/Assets

0.39

Sector 0.46

Industry 0.50

Liabilities/Assets

0.61

Sector 0.50

Industry 0.53

Growth

5Y Revenue CAGR

20.17%

Sector -

Industry -

5Y Earnings CAGR

64.34%

Sector -

Industry -

Fundamentals PNTG

DRAG THE FRAME TO SEE MORE DATA

FAIR VALUE OF Pennant Group ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$41.26

Fair Value

$15.59

Upside

-62.22%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Assets	Price ($)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
PNTG The Pennant Group Inc.	$41.26	74.51%	0.00%	45.04	3.60	7.99%	2.93%
CI Cigna Corp.	$305.81	4.49%	2.05%	11.63	1.87	16.04%	2.42%
UHS Universal Health Services Inc.	$184.89	-9.22%	0.43%	7.30	1.47	20.13%	8.42%
DGX Quest Diagnostics Inc.	$236.25	26.76%	1.42%	24.41	3.32	13.58%	9.19%
STRRP Star Equity Holdings Inc.	$9.11	2.09%	10.10%	7.62	2.39	31.31%	25.96%
ENSG The Ensign Group, Inc	$174.43	-4.01%	0.14%	27.13	4.20	15.49%	6.90%
CRVL CorVel Corporation	$81.36	13.82%	0.00%	35.14	9.91	28.21%	11.72%
OPCH Option Care Health Inc.	$31.23	12.46%	0.00%	22.82	3.80	16.63%	3.68%
JYNT The Joint Corp.	$7.35	-10.69%	0.00%	26.24	6.28	23.92%	6.49%
PGNY Progyny Inc.	$28.72	48.50%	0.00%	27.07	4.70	17.35%	6.00%
JNJ Johnson & Johnson	$259.00	37.81%	2.08%	29.04	7.19	24.76%	21.48%
LLY Eli Lilly and Compay	$1,296.12	62.47%	0.53%	42.13	33.21	78.84%	33.53%
ISRG Intuitive Surgical Inc.	$436.83	-2.08%	0.00%	49.29	8.45	17.15%	28.44%
SNY Sanofi	$41.19	-15.43%	4.38%	3.78	0.70	18.43%	14.25%
NVS Novartis AG	$153.19	18.82%	2.05%	22.56	6.86	30.41%	23.29%
TMO Thermo Fisher Scientific Inc.	$686.83	27.89%	0.27%	36.53	4.83	13.22%	15.04%
ABT Abbott Laboratories	$103.23	-17.95%	2.53%	31.55	3.35	10.61%	11.65%
MDT Medtronic PLC	$94.26	1.67%	3.02%	23.20	2.39	10.29%	13.93%
GSK GlaxoSmithKline PLC	$50.04	17.89%	3.58%	15.38	4.34	28.24%	14.54%
CVS CVS Health Corporation	$94.59	19.16%	2.89%	24.09	1.47	6.12%	1.18%
BSX Boston Scientific Corp.	$45.73	-53.92%	0.00%	17.83	2.63	14.73%	17.49%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

PNTG - Historical Dividends

no dividend paid in the period.

Current Dividend Yield

0.00%

5-year average Dividend Yield

0.00%

Current Payout

—

5-year average Payout

—

ABOUT Pennant Group

The Pennant Group Inc.

Average Investor10 user rating

4.0 (0 people)

United States

7 years

Founded: 2019

2019

Time since IPO - 7 years

9.700

Employees

The Pennant Group Inc. (United States) is listed on the Nasdaq and has a market capitalization of $1.46 billion, with shareholders equity totaling $404.44 million.

The company employs approximately 9.700 people and operates in the Health sector, within the Health Establishments industry.

Over the past 12 months, The Pennant Group Inc. reported $1.10 billion in revenue, generating net income of $32.32 million.

Key financial metrics include a P/E ratio of 45.04, a price-to-book (P/B) ratio of 3.60, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker PNTG.

Market cap

$1.46 billion

Net worth

$404.44 million

$404,442,000.00

Assets

$1.04 billion

$1,037,291,000.00

Total Shares Outstanding

34.84 million

34,835,000

Average Daily Trading Volume

$318.59 Thousand

$318,589.78

Sector

Health

Industry

Health Establishments

PNTG

PNTG revenue and profits

Financial Results PNTG

DRAG THE FRAME TO SEE MORE DATA

PNTG cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$94.59 19,21% (12M)

P/E

24.09

2.89%

ROE

6.12%

P/BV

1.47

CI - Cigna

$305.81 1,91% (12M)

P/E

11.63

2.05%

ROE

16.04%

P/BV

1.87

CNC - Centene

$70.68 98,48% (12M)

P/E

-6.73

0.00%

ROE

-22.53%

P/BV

1.52

HUM - Humana

$427.84 53,14% (12M)

P/E

39.10

0.85%

ROE

6.63%

P/BV

2.59

SNY - Sanofi

$41.19 --13,92% (12M)

P/E

3.78

4.38%

ROE

18.43%

P/BV

0.70

JNJ - Johnson & Johnson

$259.00 37,45% (12M)

P/E

29.04

2.08%

ROE

24.76%

P/BV

7.19

LLY - Eli Lilly

$1,296.12 61,23% (12M)

P/E

42.13

0.53%

ROE

78.84%

P/BV

33.21

HCA - HCA Healthcare

$461.81 7,13% (12M)

P/E

14.90

0.66%

ROE

-213.15%

P/BV

-31.76